Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
5-hydroxytryptamine receptor 2C | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2A | 0 | 7 | 1 | 8 |
5-hydroxytryptamine receptor 2A | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 2B | 0 | 7 | 0 | 7 |
Trace amine-associated receptor 1 | 0 | 0 | 2 | 2 |
GLI family zinc finger 3 | 26 | 0 | 0 | 26 |
nuclear receptor subfamily 1, group I, member 3 | 16 | 0 | 0 | 16 |
progesterone receptor | 15 | 0 | 0 | 15 |
pregnane X nuclear receptor | 16 | 0 | 0 | 16 |
estrogen nuclear receptor alpha | 30 | 0 | 0 | 30 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Coagulation factor XII | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 20 | 0 | 0 | 20 |
euchromatic histone-lysine N-methyltransferase 2 | 14 | 0 | 0 | 14 |
peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
arylsulfatase A | 4 | 0 | 0 | 4 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
NFKB1 protein, partial | 5 | 0 | 0 | 5 |
GLS protein | 7 | 0 | 0 | 7 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
flap endonuclease 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
lethal factor (plasmid) | 10 | 0 | 0 | 10 |
Cytochrome P450 3A4 | 0 | 2 | 0 | 4 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 8 | 0 | 0 | 8 |
RAR-related orphan receptor gamma | 21 | 0 | 0 | 21 |
AR protein | 28 | 0 | 0 | 28 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 11 | 0 | 0 | 11 |
retinoic acid nuclear receptor alpha variant 1 | 25 | 0 | 0 | 25 |
estrogen-related nuclear receptor alpha | 25 | 0 | 0 | 25 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
IDH1 | 9 | 0 | 0 | 9 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 18 | 0 | 0 | 18 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 25 | 0 | 0 | 25 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
geminin | 12 | 0 | 0 | 12 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 8 | 1 | 9 |
Spike glycoprotein | 9 | 1 | 1 | 11 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
glp-1 receptor, partial | 8 | 0 | 0 | 8 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
SMAD family member 2 | 5 | 0 | 0 | 5 |
SMAD family member 3 | 5 | 0 | 0 | 5 |
TDP1 protein | 14 | 0 | 0 | 14 |
TSHR protein | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 7 | 0 | 0 | 7 |
retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
67.9K protein | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 11 | 0 | 0 | 11 |
peroxisome proliferator activated receptor gamma | 14 | 0 | 0 | 14 |
aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
thyroid stimulating hormone receptor | 11 | 0 | 0 | 11 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 14 | 0 | 0 | 14 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 8 | 0 | 0 | 8 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 10 | 0 | 0 | 10 |
Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
Glutamate receptor 2 | 11 | 0 | 0 | 11 |
Alpha-synuclein | 3 | 1 | 0 | 4 |
ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
Ataxin-2 | 11 | 0 | 0 | 11 |
aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 16 | 0 | 16 |
Carbonic anhydrase 2 | 0 | 17 | 1 | 18 |
Carbonic anhydrase 4 | 0 | 14 | 0 | 14 |
Carbonic anhydrase | 0 | 12 | 0 | 12 |
Carbonic anhydrase 15 | 0 | 6 | 0 | 6 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
Microtubule-associated protein tau | 9 | 0 | 0 | 9 |
Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Arginase | 0 | 2 | 0 | 2 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 1 | 2 |
Prostaglandin G/H synthase 1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 9 | 0 | 9 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 6 | 1 | 8 |
Delta-type opioid receptor | 0 | 3 | 0 | 4 |
Kappa-type opioid receptor | 0 | 5 | 0 | 6 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Luciferase | 5 | 0 | 0 | 5 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
interleukin 8 | 4 | 0 | 0 | 4 |
PAX8 | 0 | 0 | 0 | 1 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
pregnane X receptor | 2 | 0 | 0 | 2 |
USP1 protein, partial | 9 | 0 | 0 | 9 |
caspase 7, apoptosis-related cysteine protease | 7 | 0 | 0 | 7 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
PINK1 | 2 | 0 | 0 | 2 |
G | 5 | 0 | 0 | 5 |
cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
Parkin | 3 | 0 | 0 | 3 |
heat shock protein 90 | 0 | 0 | 1 | 1 |
caspase-3 | 7 | 0 | 0 | 7 |
calcineurin A1, putative | 0 | 0 | 1 | 1 |
activating transcription factor 6 | 6 | 0 | 0 | 6 |
Histone H2A.x | 9 | 0 | 0 | 9 |
cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 2 | 0 | 2 |
cellular tumor antigen p53 isoform a | 5 | 0 | 0 | 5 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 2 | 0 | 2 |
thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
perilipin-1 | 0 | 2 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 2 |
snurportin-1 | 3 | 0 | 0 | 3 |
melanocortin receptor 4 | 0 | 1 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 2 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
hexokinase HKDC1 | 0 | 1 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 1 | 0 | 7 |
Synaptojanin-2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 6 | 0 | 0 | 6 |
Synaptojanin-1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
Interferon beta | 7 | 0 | 0 | 7 |
HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
Integrin beta-3 | 5 | 0 | 0 | 5 |
72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 5 | 0 | 0 | 5 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 1 | 0 | 7 |
Trypanothione reductase | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 1 | 0 | 7 |
Histamine H2 receptor | 6 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 1 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 1 | 0 | 7 |
TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
GABA theta subunit | 6 | 1 | 0 | 7 |
Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 1 | 0 | 7 |
Spermine oxidase | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
Fumarate hydratase | 5 | 0 | 0 | 5 |
Thrombopoietin | 4 | 0 | 0 | 4 |
Smad3 | 4 | 0 | 0 | 4 |
NADPH oxidase 1 | 0 | 2 | 0 | 2 |
polyprotein | 5 | 0 | 0 | 5 |
Snq2p | 0 | 0 | 0 | 4 |
Adenylate cyclase type 1 | 0 | 3 | 0 | 3 |
Caspase-7 | 5 | 0 | 0 | 5 |
Spike glycoprotein | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
caspase-3 | 5 | 0 | 0 | 5 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 8 | 0 | 8 |
Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
Albumin | 0 | 1 | 1 | 2 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 2 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 4 | 1 | 5 |
Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
Procathepsin L | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 7 | 0 | 7 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 8 | 0 | 8 |
Alpha-2A adrenergic receptor | 0 | 8 | 0 | 8 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 3 | 1 | 4 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
Cytochrome P450 2D6 | 0 | 5 | 1 | 7 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 8 | 0 | 8 |
Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 9 | 0 | 9 |
D(2) dopamine receptor | 0 | 10 | 1 | 14 |
Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 8 | 0 | 8 |
D | 0 | 6 | 0 | 6 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 9 | 0 | 9 |
Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 0 | 7 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 8 | 0 | 10 |
D(4) dopamine receptor | 0 | 9 | 1 | 13 |
D(1B) dopamine receptor | 0 | 3 | 0 | 5 |
Adenylate cyclase type 3 | 0 | 3 | 0 | 3 |
Alpha-2C adrenergic receptor | 0 | 6 | 0 | 6 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 6 | 0 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 12 | 2 | 14 |
Sodium-dependent dopamine transporter | 0 | 6 | 1 | 7 |
Histamine H2 receptor | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
D(1B) dopamine receptor | 0 | 5 | 0 | 5 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 3 | 0 | 3 |
Adenylate cyclase type 4 | 0 | 3 | 0 | 3 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 1B | 0 | 8 | 0 | 8 |
D(4) dopamine receptor | 0 | 5 | 0 | 5 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 12 | 2 | 14 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 4 | 0 | 8 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 8 | 0 | 8 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 8 | 1 | 9 |
D(3) dopamine receptor | 0 | 9 | 1 | 13 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 3 | 0 | 3 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 4 | 1 | 0 | 5 |
5-hydroxytryptamine receptor 6 | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
Gastrin/cholecystokinin type B receptor | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-6 | 0 | 0 | 2 | 3 |
D(2) dopamine receptor | 0 | 7 | 0 | 8 |
Calmodulin | 0 | 1 | 1 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 7 | 1 | 8 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 1 | 8 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 7 | 1 | 9 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 10 | 1 | 11 |
Adenylate cyclase type 6 | 0 | 3 | 0 | 3 |
Adenylate cyclase type 5 | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
Aldehyde oxidase | 0 | 3 | 0 | 5 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 12 | 0 | 12 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 7 | 1 | 8 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 8 | 0 | 8 |
Adenylyl cyclase 7 | 0 | 3 | 0 | 3 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 7 | 1 | 8 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
D | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 12 | 0 | 12 |
Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 7 | 1 | 8 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 2 | 0 | 2 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 0 | 3 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
ATP-citrate synthase | 0 | 0 | 0 | 1 |
Ribonuclease T | 0 | 0 | 0 | 1 |
Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 2 | 0 | 2 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 5 | 1 | 7 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Lysosomal Pro-X carboxypeptidase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
endonuclease IV | 2 | 0 | 0 | 2 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Nischarin | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Heparanase | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 7 | 0 | 7 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 7 | 1 | 8 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 5 | 0 | 5 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
GALC protein | 3 | 0 | 0 | 3 |
Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 2 | 0 | 2 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Methyl-accepting chemotaxis protein NahY | 0 | 0 | 1 | 1 |
Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Aldehyde oxidase 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 2 | 2 |
20-hydroxy-ecdysone receptor | 0 | 0 | 1 | 1 |
20-hydroxy-ecdysone receptor | 0 | 0 | 1 | 1 |
Protein ultraspiracle | 0 | 0 | 1 | 1 |
Ecdysone receptor | 0 | 0 | 1 | 1 |
Ecdysone receptor | 0 | 0 | 1 | 1 |
Chain A, Venom Allergen 2 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
Chain A, Pyruvate kinase, M2 isozyme | 0 | 1 | 0 | 1 |
Chain A, Phosphonopyruvate hydrolase | 0 | 1 | 0 | 1 |
Chain A, Phosphoenolpyruvate-protein phosphotransferase | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Vpr | 3 | 0 | 0 | 3 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
Delta-type opioid receptor | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Ornithine transcarbamylase, mitochondrial | 0 | 1 | 0 | 1 |
2-dehydropantoate 2-reductase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Fe(3+)-Zn(2+) purple acid phosphatase | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Mcl-1 | 0 | 1 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Chain A, MALTOPORIN | 0 | 0 | 1 | 1 |
Chain B, MALTOPORIN | 0 | 0 | 1 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Repressor | 0 | 0 | 1 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |